These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 7544868)
1. Alterations of a dominant epitope of lymphocytic choriomeningitis virus which affect class I binding and cytotoxic T cell recognition. Hioe CE; Frelinger JA Mol Immunol; 1995 Jul; 32(10):725-31. PubMed ID: 7544868 [TBL] [Abstract][Full Text] [Related]
3. Mutations inside but not outside the peptide binding cleft of the H-2 Ld molecule affect CTL recognition and binding of the nucleoprotein peptide from the lymphocytic choriomeningitis virus. Hioe CE; McKinney DM; Frelinger JA; McMillan M Immunogenetics; 1994; 40(3):222-9. PubMed ID: 7518804 [TBL] [Abstract][Full Text] [Related]
4. Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection. Oldstone MB; Lewicki H; Borrow P; Hudrisier D; Gairin JE J Virol; 1995 Dec; 69(12):7423-9. PubMed ID: 7494247 [TBL] [Abstract][Full Text] [Related]
5. Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus. Whitton JL; Gebhard JR; Lewicki H; Tishon A; Oldstone MB J Virol; 1988 Mar; 62(3):687-95. PubMed ID: 2448497 [TBL] [Abstract][Full Text] [Related]
6. Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus. Yanagi Y; Maekawa R; Cook T; Kanagawa O; Oldstone MB J Virol; 1990 Dec; 64(12):5919-26. PubMed ID: 1700830 [TBL] [Abstract][Full Text] [Related]
7. Virus-specific, CD8+ major histocompatibility complex class I-restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus-infected beta2-microglobulin-deficient mice. Quinn DG; Zajac AJ; Hioe CE; Frelinger JA J Virol; 1997 Nov; 71(11):8392-6. PubMed ID: 9343195 [TBL] [Abstract][Full Text] [Related]
8. CTL escape viral variants. I. Generation and molecular characterization. Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078 [TBL] [Abstract][Full Text] [Related]
9. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes. Slifka MK; Shen H; Matloubian M; Jensen ER; Miller JF; Ahmed R J Virol; 1996 May; 70(5):2902-10. PubMed ID: 8627765 [TBL] [Abstract][Full Text] [Related]
10. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes. von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447 [TBL] [Abstract][Full Text] [Related]
11. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants. Byrne JA; Ahmed R; Oldstone MB J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788 [TBL] [Abstract][Full Text] [Related]
12. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. van der Most RG; Murali-Krishna K; Whitton JL; Oseroff C; Alexander J; Southwood S; Sidney J; Chesnut RW; Sette A; Ahmed R Virology; 1998 Jan; 240(1):158-67. PubMed ID: 9448700 [TBL] [Abstract][Full Text] [Related]
13. Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule. Yanagi Y; Tishon A; Lewicki H; Cubitt BA; Oldstone MB J Virol; 1992 Apr; 66(4):2527-31. PubMed ID: 1372370 [TBL] [Abstract][Full Text] [Related]
14. Peptides control the gain and loss of allele specificity by mutated MHC class I molecules. Hengel H; Burke K; Kyburz D; Zinkernagel RM; Koszinowski UH J Immunol; 1995 May; 154(9):4557-64. PubMed ID: 7722309 [TBL] [Abstract][Full Text] [Related]
15. Molecular and functional dissection of the H-2Db-restricted subdominant cytotoxic T-cell response to lymphocytic choriomeningitis virus. Hudrisier D; Riond J; Gairin JE J Virol; 2001 Mar; 75(5):2468-71. PubMed ID: 11160751 [TBL] [Abstract][Full Text] [Related]
16. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501 [TBL] [Abstract][Full Text] [Related]
17. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules. Hudrisier D; Oldstone MB; Gairin JE Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947 [TBL] [Abstract][Full Text] [Related]
18. Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Klavinskis LS; Whitton JL; Joly E; Oldstone MB Virology; 1990 Oct; 178(2):393-400. PubMed ID: 1699348 [TBL] [Abstract][Full Text] [Related]
19. In vivo selection of a lymphocytic choriomeningitis virus variant that affects recognition of the GP33-43 epitope by H-2Db but not H-2Kb. Puglielli MT; Zajac AJ; van der Most RG; Dzuris JL; Sette A; Altman JD; Ahmed R J Virol; 2001 Jun; 75(11):5099-107. PubMed ID: 11333891 [TBL] [Abstract][Full Text] [Related]
20. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. van der Most RG; Sette A; Oseroff C; Alexander J; Murali-Krishna K; Lau LL; Southwood S; Sidney J; Chesnut RW; Matloubian M; Ahmed R J Immunol; 1996 Dec; 157(12):5543-54. PubMed ID: 8955205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]